QuickView for FR180204 (compound)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens

1. Long-Lasting Activity of ERK Kinase Depends on NFATc1 Induction and Is Involved in Cell Migration-Fu…
2. A platform for studying the transfer of Chlamydia pneumoniae infection between respiratory epitheliu…
3. Multi-gram scale synthesis of FR180204.
4. Waveform generation is controlled by phosphorylation and swimming direction is controlled by Ca2+ in…
5. Effect of API-1 and FR180204 on cell proliferation and apoptosis in human DLD-1 and LoVo colorectal …

There were no clinical trials for FR180204